BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25471065)

  • 1. Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling.
    Liu W; Cao H; Ye C; Chang C; Lu M; Jing Y; Zhang D; Yao X; Duan Z; Xia H; Wang YC; Jiang J; Liu MF; Yan J; Ying H
    Nat Commun; 2014 Dec; 5():5684. PubMed ID: 25471065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation.
    Sopasakis VR; Liu P; Suzuki R; Kondo T; Winnay J; Tran TT; Asano T; Smyth G; Sajan MP; Farese RV; Kahn CR; Zhao JJ
    Cell Metab; 2010 Mar; 11(3):220-30. PubMed ID: 20197055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic exosome-derived miR-130a-3p attenuates glucose intolerance via suppressing PHLPP2 gene in adipocyte.
    Wu J; Dong T; Chen T; Sun J; Luo J; He J; Wei L; Zeng B; Zhang H; Li W; Liu J; Chen X; Su M; Ni Y; Jiang Q; Zhang Y; Xi Q
    Metabolism; 2020 Feb; 103():154006. PubMed ID: 31715176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.
    Andrés-Blasco I; Herrero-Cervera A; Vinué Á; Martínez-Hervás S; Piqueras L; Sanz MJ; Burks DJ; González-Navarro H
    J Endocrinol; 2015 Dec; 227(3):179-91. PubMed ID: 26423094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo.
    Bhatia H; Pattnaik BR; Datta M
    Int J Obes (Lond); 2016 May; 40(5):861-9. PubMed ID: 26499439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b.
    Kornfeld JW; Baitzel C; Könner AC; Nicholls HT; Vogt MC; Herrmanns K; Scheja L; Haumaitre C; Wolf AM; Knippschild U; Seibler J; Cereghini S; Heeren J; Stoffel M; Brüning JC
    Nature; 2013 Feb; 494(7435):111-5. PubMed ID: 23389544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.
    Amrutkar M; Cansby E; Chursa U; Nuñez-Durán E; Chanclón B; Ståhlman M; Fridén V; Mannerås-Holm L; Wickman A; Smith U; Bäckhed F; Borén J; Howell BW; Mahlapuu M
    Diabetes; 2015 Aug; 64(8):2791-804. PubMed ID: 25845663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
    Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
    Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of Nck1 attenuates hepatic ER stress signaling and improves glucose tolerance and insulin signaling in liver of obese mice.
    Latreille M; Laberge MK; Bourret G; Yamani L; Larose L
    Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E423-34. PubMed ID: 20587749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Hepatic miR-22-3p Expression Impairs Gluconeogenesis by Silencing the Wnt-Responsive Transcription Factor Tcf7.
    Kaur K; Vig S; Srivastava R; Mishra A; Singh VP; Srivastava AK; Datta M
    Diabetes; 2015 Nov; 64(11):3659-69. PubMed ID: 26193896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver.
    Huang X; Yang C; Luo Y; Jin C; Wang F; McKeehan WL
    Diabetes; 2007 Oct; 56(10):2501-10. PubMed ID: 17664243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel function of microRNA 130a-3p in hepatic insulin sensitivity and liver steatosis.
    Xiao F; Yu J; Liu B; Guo Y; Li K; Deng J; Zhang J; Wang C; Chen S; Du Y; Lu Y; Xiao Y; Zhang Z; Guo F
    Diabetes; 2014 Aug; 63(8):2631-42. PubMed ID: 24677715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway.
    Liu Y; Zhou X; Xiao Y; Li C; Huang Y; Guo Q; Su T; Fu L; Luo L
    J Endocrinol; 2020 Jun; 245(3):411-423. PubMed ID: 32252024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hepatic protein tyrosine phosphatase 1B and methionine restriction on hepatic and whole-body glucose and lipid metabolism in mice.
    Lees EK; Krol E; Shearer K; Mody N; Gettys TW; Delibegovic M
    Metabolism; 2015 Feb; 64(2):305-14. PubMed ID: 25468142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microRNA-29 Family Dictates the Balance Between Homeostatic and Pathological Glucose Handling in Diabetes and Obesity.
    Dooley J; Garcia-Perez JE; Sreenivasan J; Schlenner SM; Vangoitsenhoven R; Papadopoulou AS; Tian L; Schonefeldt S; Serneels L; Deroose C; Staats KA; Van der Schueren B; De Strooper B; McGuinness OP; Mathieu C; Liston A
    Diabetes; 2016 Jan; 65(1):53-61. PubMed ID: 26696639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PANDER transgenic mice display fasting hyperglycemia and hepatic insulin resistance.
    Robert-Cooperman CE; Dougan GC; Moak SL; Athanason MG; Kuehl MN; Bell-Temin H; Stevens SM; Burkhardt BR
    J Endocrinol; 2014 Mar; 220(3):219-31. PubMed ID: 24468680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RABL2 Is Required for Hepatic Fatty Acid Homeostasis and Its Dysfunction Leads to Steatosis and a Diabetes-Like State.
    Yi Lo JC; O'Connor AE; Andrews ZB; Lo C; Tiganis T; Watt MJ; O'Bryan MK
    Endocrinology; 2016 Dec; 157(12):4732-4743. PubMed ID: 27732084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.